Herantis Pharma to participate in Bio-Europe Spring and AD/PD 2023
Herantis Pharma Plc, Press Release, 9 March 2023 at 09:00 A.M. EET Herantis Pharma Plc (“Herantis”), developing disease-modifying therapies for Parkinson’s disease, today announced participation in the following conferences: Bio-Europe Spring Location: Basel, Switzerland Dates: March 20[th] – 22[nd], 2023 Attendees: CEO Antti Vuolanto, DSc and CSO Dr. Henri Huttunen, PhD AD/PD 2023: International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders Location: Gothenburg, Sweden Dates: March 28[th] – April 1[th], 2023 1. Poster